These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26635137)

  • 1. Why oral opioids may not be effective in a subset of chronic pain patients.
    Tennant F
    Postgrad Med; 2016 Jan; 128(1):18-22. PubMed ID: 26635137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid regimens in patients with chronic pain with multiple cytochrome P450 defects.
    Tennant F
    J Opioid Manag; 2015; 11(3):237-42. PubMed ID: 25985808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
    Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
    Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL; Carpenter DM; Minkoff JR
    Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study.
    Barreveld AM; Correll DJ; Liu X; Max B; McGowan JA; Shovel L; Wasan AD; Nedeljkovic SS
    Pain Med; 2013 Jun; 14(6):925-34. PubMed ID: 23786558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of opioid use and improvement in chronic pain in opioid-experienced patients after topical analgesic treatment: an exploratory analysis.
    Gudin JA; Brennan MJ; Harris ED; Hurwitz PL; Dietze DT; Strader JD
    Postgrad Med; 2018 Jan; 130(1):42-51. PubMed ID: 29224410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies.
    Merchant S; Provenzano D; Mody S; Ho KF; Etropolski M
    J Opioid Manag; 2013; 9(1):51-61. PubMed ID: 23709304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
    Taber L; Lynch SY; He E; Ripa SR
    Postgrad Med; 2016 Jan; 128(1):23-33. PubMed ID: 26681111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
    Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
    Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes and Beliefs of Working and Work-Disabled People with Chronic Pain Prescribed Long-Term Opioids.
    Robinson JP; Dansie EJ; Wilson HD; Rapp S; Turk DC
    Pain Med; 2015 Jul; 16(7):1311-24. PubMed ID: 25929427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Medications in the Management of Chronic Abdominal Pain.
    Wang D
    Curr Pain Headache Rep; 2017 Aug; 21(9):40. PubMed ID: 28791598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
    Arora S; Setnik B; Michael D; Hudson JD; Clemmer R; Meisner P; Pixton GC; Goli V; Sommerville KW
    J Opioid Manag; 2014; 10(6):423-36. PubMed ID: 25531960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European survey of chronic pain patients: results for Germany.
    Müller-Schwefe GH
    Curr Med Res Opin; 2011 Nov; 27(11):2099-106. PubMed ID: 21933101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent intrathecal opioid escalation in chronic noncancer pain patients.
    Hayek SM; Veizi IE; Narouze SN; Mekhail N
    Pain Med; 2011 Aug; 12(8):1179-89. PubMed ID: 21810164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
    Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
    Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.